查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826995

2025年全球脊椎狭窄治疗市场报告

Spinal Stenosis Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，脊椎狭窄治疗市场稳定成长，预计2024年将达102亿美元，2025年将达106.1亿美元，复合年增长率为4.1%。预测期内的增长可归因于退化性脊椎疾病盛行率的上升、全球老年人口的增长、人们对脊椎相关疾病认识的提高、医疗支出和保险覆盖率的提高，以及对微创外科手术的需求不断增长。

预计未来几年脊椎狭窄治疗市场将稳定成长，到2029年将达到123.5亿美元，复合年增长率为3.9%。预测期内的增长可归因于脊椎狭窄及相关退化性疾病的盛行率不断上升、微创外科手术的普及、对非手术治疗方案的需求不断增长、人们对脊椎健康和治疗方案的认识不断提高，以及对疼痛管理和再生疗法的日益关注。预测期内的主要趋势包括植入和器械技术的进步、远端保健和数位健康解决方案的普及、支持性监管环境和优惠的报销政策、人工智慧和机器人技术在手术计划和治疗中的整合，以及对个人化治疗方法和患者特定解决方案的关注。

脊椎狭窄症的治疗涵盖医疗和外科干预，旨在缓解脊椎狭窄对脊髓和神经造成的压力。治疗方案包括物理治疗、疼痛管理、抗发炎药物、皮质类固醇注射，以及在严重病例中采用切除术和脊椎融合手术术等外科手术，以改善活动能力并缓解不适。

脊椎狭窄症的主要治疗类型是颈椎管狭窄症和腰椎管狭窄症。颈椎脊椎狭窄症是指颈部椎管狭窄，压迫脊椎和神经而发生的疾病。治疗方法多种多样，包括药物治疗、物理治疗和手术，适用于各种终端用户，包括医院、居家医疗、专科诊所和其他医疗机构。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供脊椎狭窄治疗市场统计数据，例如全球市场规模、区域份额、脊椎狭窄治疗市场份额的竞争对手、详细的脊椎狭窄治疗细分市场、市场趋势以及脊椎狭窄治疗行业的商机。这份脊椎狭窄治疗市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整展望。

未来五年3.9%的成长预测较先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致比利时和瑞典开发的硬膜外类固醇注射套件和可生物降解脊椎移植的价格上涨，从而延长保守治疗週期并增加介入性疼痛管理的成本，从而阻碍美国患者的治疗效果。互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响也将产生更广泛的影响。

脊椎疾病盛行率的不断上升预计将推动脊椎狭窄治疗市场的成长。脊椎疾病包括影响脊椎骨骼、椎间盘、神经和软组织的疾病，会导致疼痛、活动受限和神经系统症状。人口老化、久坐不动的生活方式、肥胖、不良姿势、职业危害和诊断能力的提高等因素导致这些疾病的发病率上升。脊椎狭窄治疗旨在缓解神经压迫、减轻疼痛并增加退化性椎间盘疾病和椎间盘突出等疾病中的活动能力。例如，2023 年 5 月，美国医疗设备公司 Spinal Cord, Inc. 报告称，美国每年约有 18,000 例新的脊髓损伤 (SCI) 病例，估计全国目前有 302,000 人患有 SCI。因此，脊椎疾病盛行率的不断上升正在刺激脊椎狭窄治疗市场的扩张。

脊椎狭窄治疗市场的主要企业正专注于技术进步，例如微创手术 (MIS)植入，以改善手术选择、提高患者预后并缩短恢復时间。 MIS植入是设计用于使用微创技术植入的医疗设备，与传统开放性手术相比，它可减少创伤、恢復时间和併发症。例如，2022 年 7 月，美国医疗设备公司 Aurora Spine 获得了美国食品药物管理局(FDA) 的扩大批准，可用于其用于治疗腰椎脊椎狭窄的 ZIP MIS植入。脊椎管狭窄是一种以脊椎狭窄为特征的疾病，会导致下背部和腿部疼痛。先前，该植入已被核准用于治疗退化性椎间盘疾病、椎间滑脱、创伤和肿瘤。此次扩大核准将使医生能够治疗更广泛的患者，并为脊椎狭窄提供更有效的治疗方法选择。

2024年10月，美国医疗保健公司史赛克（Stryker Corporation）收购了Vertos Medical, Inc.，收购金额未揭露。此次收购将增强史赛克针对慢性腰痛的非门诊手术治疗产品组合，扩大其在门诊手术中心的业务，并增强其介入性疼痛管理解决方案。 Vertos Medical是一家美国医疗设备製造商，专注于腰椎脊椎狭窄症的微创治疗。

脊椎狭窄治疗市场由提供替代疗法和整体疗法、辅助和支持性护理以及先进和再生疗法等服务的营业单位所赚取的收益构成。市场价值还包括服务提供者销售的或包含在其服务产品中的任何相关商品的价值。脊椎狭窄治疗市场还包括药品、医疗设备和手术器械的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球脊椎狭窄症治疗：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球脊椎狭窄治疗市场：成长率分析
  • 全球脊椎狭窄治疗市场表现：规模与成长，2019-2024
  • 全球脊椎狭窄治疗市场预测：规模与成长，2024-2029年，2034年
  • 全球脊椎狭窄症治疗：总目标市场（TAM）

第六章 市场细分

  • 全球脊椎狭窄治疗市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 颈椎狭窄
  • 脊椎狭窄症
  • 全球脊椎狭窄症治疗市场（依治疗、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 药品
  • 物理治疗
  • 外科手术
  • 其他治疗方法
  • 全球脊椎狭窄治疗市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 居家护理
  • 专科诊所
  • 其他最终用户
  • 全球脊椎狭窄治疗市场：依颈椎狭窄类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 物理治疗
  • 製药
  • 脊椎注射
  • 减压手术
  • 脊椎融合手术
  • 全球脊椎狭窄症治疗市场：细分：脊椎狭窄症（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 硬脊膜外类固醇注射
  • 微创手术
  • 切除术
  • 人工全人工椎间盘置换术

第七章 区域和国家分析

  • 全球脊椎狭窄治疗市场：按地区、结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球脊椎狭窄治疗市场：按国家、结果和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 脊椎狭窄治疗市场：竞争格局
  • 脊椎狭窄治疗市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sumitomo Dainippon Pharma Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Ono Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Stryker Corporation
  • Globus Medical Inc.
  • Orthofix Holdings Inc.
  • Aesculap Implant Systems LLC
  • Alphatec Spine Inc
  • RTI Surgical Holdings Inc
  • B. Braun Melsungen AG
  • Spinal Elements Inc.
  • Xtant Medical Holdings Inc.
  • Precision Spine Inc.
  • Spineart SA
  • Yungjin Pharm Co. Ltd
  • Zavation Medical Products LLC
  • Aurora Spine Corporation
  • Empirical Spine Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年脊椎狭窄治疗市场：提供新机会的国家
  • 2029年脊椎狭窄治疗市场：细分领域带来新机会
  • 2029年脊椎狭窄治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34155u

Spinal stenosis treatment encompasses medical and surgical interventions designed to alleviate pressure on the spinal cord and nerves caused by the narrowing of the spinal canal. Treatment options include physical therapy, pain management, anti-inflammatory medications, corticosteroid injections, and, in severe cases, surgical procedures such as laminectomy or spinal fusion to improve mobility and reduce discomfort.

The primary types of spinal stenosis treatment are cervical stenosis and lumbar stenosis. Cervical stenosis occurs when the spinal canal narrows in the neck region, exerting pressure on the spinal cord and nerves, which may result in pain, numbness, or weakness in the arms and legs. Various treatment approaches, including medication, physical therapy, and surgery, are utilized by different end users, such as hospitals, home care, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The spinal stenosis treatment market research report is one of a series of new reports from The Business Research Company that provides spinal stenosis treatment market statistics, including the spinal stenosis treatment industry global market size, regional shares, competitors with the spinal stenosis treatment market share, detailed spinal stenosis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the spinal stenosis treatment industry. This spinal stenosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The spinal stenosis treatment market size has grown steadily in recent years. It will grow from $10.2 billion in 2024 to $10.61 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to the rising prevalence of degenerative spinal conditions, increasing geriatric population globally, growing awareness of spine-related disorders, increased healthcare spending and insurance coverage, and rising demand for minimally invasive surgical procedures.

The spinal stenosis treatment market size is expected to see steady growth in the next few years. It will grow to $12.35 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to the growing prevalence of spinal stenosis and related degenerative conditions, rising adoption of minimally invasive surgical procedures, growing demand for non-surgical treatment options, rising awareness of spine health and treatment options, and increasing focus on pain management and regenerative therapies. Major trends in the forecast period include advancements in implant and device technology, adoption of telehealth and digital health solutions, a supportive regulatory landscape and favorable reimbursement policies, integration of AI and robotics in surgical planning and treatment, a focus on personalized treatment approaches, and patient-specific solutions.

The forecast of 3.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. patient outcomes by inflating prices of epidural steroid injection kits and biodegradable spinal implants developed in Belgium and Sweden, resulting in prolonged conservative care cycles and higher interventional pain management expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of spinal disorders is expected to drive the growth of the spinal stenosis treatment market. Spinal disorders encompass conditions affecting the spine's bones, discs, nerves, or soft tissues, leading to pain, mobility limitations, or neurological symptoms. Factors such as aging, sedentary lifestyles, obesity, poor posture, occupational hazards, and improved diagnostic capabilities contribute to the rising incidence of these conditions. Spinal stenosis treatments aim to relieve nerve compression, reduce pain, and enhance mobility in disorders such as degenerative disc disease and herniated discs. For example, in May 2023, Spinal Cord, Inc., a US-based medical device company, reported that approximately 18,000 new spinal cord injury (SCI) cases occur annually in the United States, with an estimated 302,000 individuals currently living with SCI nationwide. As a result, the increasing prevalence of spinal disorders is fueling the expansion of the spinal stenosis treatment market.

Leading companies in the spinal stenosis treatment market are focusing on technological advancements, such as minimally invasive surgery (MIS) implants, to improve surgical options, enhance patient outcomes, and shorten recovery times. MIS implants are medical devices designed for implantation using minimally invasive techniques, which reduce trauma, recovery time, and complications compared to traditional open surgery. For instance, in July 2022, Aurora Spine, a US-based medical device company, received expanded U.S. Food and Drug Administration (FDA) clearance for its ZIP MIS implants for lumbar spinal stenosis. This condition, characterized by the narrowing of the spinal canal, causes back and leg pain. Previously, the implants were approved for treating degenerative disc disease, spondylolisthesis, trauma, and tumors. The expanded approval allows physicians to treat a broader range of patients, increasing the availability of effective treatment options for spinal stenosis.

In October 2024, Stryker Corporation, a US-based medical company, acquired Vertos Medical, Inc. for an undisclosed amount. This acquisition strengthens Stryker's portfolio of non-surgical treatments for chronic lower back pain and expands its presence in ambulatory surgery centers, reinforcing its interventional pain management solutions. Vertos Medical, a US-based medical device company, specializes in minimally invasive treatments for lumbar spinal stenosis.

Major players in the spinal stenosis treatment market are Johnson & Johnson, Medtronic plc, Zimmer Biomet Holdings Inc., Sumitomo Dainippon Pharma Co. Ltd, Ono Pharmaceutical Co. Ltd, Stryker Corporation, Globus Medical Inc., Orthofix Holdings Inc., Aesculap Implant Systems LLC, Alphatec Spine Inc, RTI Surgical Holdings Inc, B. Braun Melsungen AG, Spinal Elements Inc., Xtant Medical Holdings Inc., Precision Spine Inc., Spineart SA, Yungjin Pharm Co. Ltd, Zavation Medical Products LLC, Aurora Spine Corporation, and Empirical Spine Inc.

North America was the largest region in the spinal stenosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spinal stenosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spinal stenosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal stenosis treatment market consists of revenues earned by entities by providing services such as alternative and holistic therapies, assistive and supportive care, and advanced and regenerative therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The spinal stenosis treatment market also includes sales of pharmaceuticals, medical devices, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Stenosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal stenosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spinal stenosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spinal stenosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cervical Stenosis; Lumbar Stenosis
  • 2) By Treatment: Medication; Physical Therapy; Surgery; Other Treatments
  • 3) By End Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Cervical Stenosis: Physical Therapy; Medications; Spinal Injections; Decompression Surgery; Spinal Fusion
  • 2) By Lumbar Stenosis: Pain Management; Epidural Steroid Injections; Minimally Invasive Procedures; Laminectomy; Artificial Disc Replacement
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet Holdings Inc.; Sumitomo Dainippon Pharma Co. Ltd; Ono Pharmaceutical Co. Ltd; Stryker Corporation; Globus Medical Inc.; Orthofix Holdings Inc.; Aesculap Implant Systems LLC; Alphatec Spine Inc; RTI Surgical Holdings Inc; B. Braun Melsungen AG; Spinal Elements Inc.; Xtant Medical Holdings Inc.; Precision Spine Inc.; Spineart SA; Yungjin Pharm Co. Ltd; Zavation Medical Products LLC; Aurora Spine Corporation; Empirical Spine Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spinal Stenosis Treatment Market Characteristics

3. Spinal Stenosis Treatment Market Trends And Strategies

4. Spinal Stenosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Spinal Stenosis Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Spinal Stenosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Spinal Stenosis Treatment Market Growth Rate Analysis
  • 5.4. Global Spinal Stenosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Spinal Stenosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Spinal Stenosis Treatment Total Addressable Market (TAM)

6. Spinal Stenosis Treatment Market Segmentation

  • 6.1. Global Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cervical Stenosis
  • Lumbar Stenosis
  • 6.2. Global Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medication
  • Physical Therapy
  • Surgery
  • Other Treatments
  • 6.3. Global Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users
  • 6.4. Global Spinal Stenosis Treatment Market, Sub-Segmentation Of Cervical Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Physical Therapy
  • Medications
  • Spinal Injections
  • Decompression Surgery
  • Spinal Fusion
  • 6.5. Global Spinal Stenosis Treatment Market, Sub-Segmentation Of Lumbar Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Epidural Steroid Injections
  • Minimally Invasive Procedures
  • Laminectomy
  • Artificial Disc Replacement

7. Spinal Stenosis Treatment Market Regional And Country Analysis

  • 7.1. Global Spinal Stenosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Spinal Stenosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spinal Stenosis Treatment Market

  • 8.1. Asia-Pacific Spinal Stenosis Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spinal Stenosis Treatment Market

  • 9.1. China Spinal Stenosis Treatment Market Overview
  • 9.2. China Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spinal Stenosis Treatment Market

  • 10.1. India Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spinal Stenosis Treatment Market

  • 11.1. Japan Spinal Stenosis Treatment Market Overview
  • 11.2. Japan Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spinal Stenosis Treatment Market

  • 12.1. Australia Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spinal Stenosis Treatment Market

  • 13.1. Indonesia Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spinal Stenosis Treatment Market

  • 14.1. South Korea Spinal Stenosis Treatment Market Overview
  • 14.2. South Korea Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spinal Stenosis Treatment Market

  • 15.1. Western Europe Spinal Stenosis Treatment Market Overview
  • 15.2. Western Europe Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spinal Stenosis Treatment Market

  • 16.1. UK Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spinal Stenosis Treatment Market

  • 17.1. Germany Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spinal Stenosis Treatment Market

  • 18.1. France Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spinal Stenosis Treatment Market

  • 19.1. Italy Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spinal Stenosis Treatment Market

  • 20.1. Spain Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spinal Stenosis Treatment Market

  • 21.1. Eastern Europe Spinal Stenosis Treatment Market Overview
  • 21.2. Eastern Europe Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spinal Stenosis Treatment Market

  • 22.1. Russia Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spinal Stenosis Treatment Market

  • 23.1. North America Spinal Stenosis Treatment Market Overview
  • 23.2. North America Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spinal Stenosis Treatment Market

  • 24.1. USA Spinal Stenosis Treatment Market Overview
  • 24.2. USA Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spinal Stenosis Treatment Market

  • 25.1. Canada Spinal Stenosis Treatment Market Overview
  • 25.2. Canada Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spinal Stenosis Treatment Market

  • 26.1. South America Spinal Stenosis Treatment Market Overview
  • 26.2. South America Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spinal Stenosis Treatment Market

  • 27.1. Brazil Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spinal Stenosis Treatment Market

  • 28.1. Middle East Spinal Stenosis Treatment Market Overview
  • 28.2. Middle East Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spinal Stenosis Treatment Market

  • 29.1. Africa Spinal Stenosis Treatment Market Overview
  • 29.2. Africa Spinal Stenosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Spinal Stenosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Spinal Stenosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spinal Stenosis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Spinal Stenosis Treatment Market Competitive Landscape
  • 30.2. Spinal Stenosis Treatment Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sumitomo Dainippon Pharma Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ono Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Spinal Stenosis Treatment Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Globus Medical Inc.
  • 31.3. Orthofix Holdings Inc.
  • 31.4. Aesculap Implant Systems LLC
  • 31.5. Alphatec Spine Inc
  • 31.6. RTI Surgical Holdings Inc
  • 31.7. B. Braun Melsungen AG
  • 31.8. Spinal Elements Inc.
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. Precision Spine Inc.
  • 31.11. Spineart SA
  • 31.12. Yungjin Pharm Co. Ltd
  • 31.13. Zavation Medical Products LLC
  • 31.14. Aurora Spine Corporation
  • 31.15. Empirical Spine Inc

32. Global Spinal Stenosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spinal Stenosis Treatment Market

34. Recent Developments In The Spinal Stenosis Treatment Market

35. Spinal Stenosis Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Spinal Stenosis Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Spinal Stenosis Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Spinal Stenosis Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer